Showing 1 - 1 results of 1 for search 'Gallo L', query time: 0.01s Refine Results
  1. 1
    Tildrakizumab for the Treatment of Moderate-to-Severe Psoriasis: Results from 52 Weeks Real-Life Retrospective Study

    Tildrakizumab for the Treatment of Moderate-to-Severe Psoriasis: Results from 52 Weeks Real-Life Retrospective Study by Ruggiero A, Fabbrocicni G, Cacciapuoti S, Potestio L, Gallo L, Megna M

    Published 2023
    Connect to this object online.
    Book
    Save to List
    Saved in:

Search Tools: